Article Text

Download PDFPDF
Invasive Neisseria meningitidis subtype C in gay, bisexual and other men who have sex with men: a systematic review
  1. Lucy Rabuszko1,
  2. Sarah Stuart-George2,
  3. Callum Chessell2,
  4. Colin Fitzpatrick3,
  5. Deborah Williams3,
  6. Daniel Richardson2,3
  1. 1Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK
  2. 2Sexual Health & HIV Medicine, Brighton and Sussex Medical School, Brighton, UK
  3. 3Sexual Health & HIV, University Hospitals Sussex NHS Foundation Trust, Brighton, UK
  1. Correspondence to Professor Daniel Richardson; daniel.richardson7{at}nhs.net

Abstract

Introduction Outbreaks of invasive Neisseria meningitidis subtype C in networks of gay, bisexual and other men who have sex with men (MSM) have been reported. We aimed to explore any factors seen in MSM with invasive N.meningitidis subtype C.

Method We searched three bibliographical databases for manuscripts written in English exploring at least one factor seen in MSM with invasive N. meningitidis subtype C published up to May 2024. Following an initial search, removal of duplicates and abstract review, two authors independently reviewed full-text manuscripts and performed a risk of bias assessment using the Joanna Briggs Institute toolkit. Narrative data were synthesised to generate themes.

Results 16 manuscripts were included in this review from the USA (n=10), Germany (n=2), France (n=2), Canada (n=1) and Italy (n=1) and consisted of nine case series, four cross-sectional studies, two case reports and one case–control study published between 2003 and 2024 involving 236 MSM with invasive N. meningitidis subtype C, of which at least 64 died. We have highlighted some demographic (African-American or Hispanic identity in the USA, living with HIV), behavioural (kissing, sharing drinks, visiting sex-on-premises venues, visiting gay-oriented venues, using websites/mobile phone apps to meet sexual partners, recreational drug use, multiple and non-regular sexual partners) and infection (previous Chlamydia trachomatis, Treponema pallidum, Neisseria gonorrhoeae, Mpox) factors in MSM with invasive N. meningitidis subtype C.

Conclusion These data serve as an important resource to inform and target future public health strategies and outbreak control measures for the prevention of invasive N. meningitidis subtype C in MSM.

PROSPERO registration number CRD42024543551.

  • MEN
  • NEISSERIA MENINGITIDIS
  • MENINGITIS
  • Homosexuality, Male

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text

Footnotes

  • Handling editor Stefano Rusconi

  • Contributors DR came up with the study concept and designed the study protocol, LR conducted the data search, LR, SS DR independently reviewed the manuscripts for eligibility, LR and DR independently conducted the risk of bias assessment, LR and DR conducted the data synthesis and LR, SS, CC, CF, DW and DR all contributed to the final manuscript. DR is acting as the guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.